Pieter Neels

1.0k total citations
36 papers, 627 citations indexed

About

Pieter Neels is a scholar working on Infectious Diseases, Health and Epidemiology. According to data from OpenAlex, Pieter Neels has authored 36 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 14 papers in Health and 11 papers in Epidemiology. Recurrent topics in Pieter Neels's work include Vaccine Coverage and Hesitancy (14 papers), Viral gastroenteritis research and epidemiology (12 papers) and SARS-CoV-2 and COVID-19 Research (11 papers). Pieter Neels is often cited by papers focused on Vaccine Coverage and Hesitancy (14 papers), Viral gastroenteritis research and epidemiology (12 papers) and SARS-CoV-2 and COVID-19 Research (11 papers). Pieter Neels collaborates with scholars based in Belgium, United States and Switzerland. Pieter Neels's co-authors include Berten Ceulemans, Philippe G. Jorens, Lieven Lagae, Marc Boel, Germaine Hanquet, Marc Baay, Pierre Van Damme, Béatris Mastelic, Giuseppe Del Giudice and Hana Golding and has published in prestigious journals such as Frontiers in Immunology, Epilepsia and Vaccine.

In The Last Decade

Pieter Neels

35 papers receiving 598 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pieter Neels Belgium 14 224 137 133 115 114 36 627
K Johansen Sweden 15 352 1.6× 25 0.2× 394 3.0× 72 0.6× 273 2.4× 37 850
Michael Lock United States 17 241 1.1× 628 4.6× 239 1.8× 417 3.6× 35 0.3× 37 1.4k
Katelijn Vandemaele Switzerland 12 688 3.1× 55 0.4× 322 2.4× 37 0.3× 119 1.0× 14 1.1k
Stephen Vreden French Guiana 18 222 1.0× 203 1.5× 114 0.9× 90 0.8× 17 0.1× 73 1.0k
David Lewis United States 14 187 0.8× 33 0.2× 171 1.3× 27 0.2× 19 0.2× 31 691
Rebecca Grant France 13 300 1.3× 17 0.1× 140 1.1× 14 0.1× 48 0.4× 31 708
Ann Schluederberg United States 15 231 1.0× 245 1.8× 361 2.7× 10 0.1× 60 0.5× 36 808
Francisca Abanyie United States 11 131 0.6× 30 0.2× 110 0.8× 72 0.6× 8 0.1× 16 691
Kimberly E. Mace United States 16 102 0.5× 23 0.2× 54 0.4× 117 1.0× 18 0.2× 36 882
Lance Turtle United Kingdom 21 1.1k 4.7× 9 0.1× 229 1.7× 49 0.4× 53 0.5× 67 1.7k

Countries citing papers authored by Pieter Neels

Since Specialization
Citations

This map shows the geographic impact of Pieter Neels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pieter Neels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pieter Neels more than expected).

Fields of papers citing papers by Pieter Neels

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pieter Neels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pieter Neels. The network helps show where Pieter Neels may publish in the future.

Co-authorship network of co-authors of Pieter Neels

This figure shows the co-authorship network connecting the top 25 collaborators of Pieter Neels. A scholar is included among the top collaborators of Pieter Neels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pieter Neels. Pieter Neels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jamrozik, Euzebiusz, et al.. (2024). Ethical approval for controlled human infectious model clinical trial protocols – A workshop report. Biologicals. 85. 101748–101748.
2.
Bollaerts, Kaatje, Chloé Wyndham-Thomas, Elizabeth Miller, et al.. (2024). The role of real-world evidence for regulatory and public health decision-making for Accelerated Vaccine Deployment- a meeting report. Biologicals. 85. 101750–101750. 13 indexed citations
3.
Marchant, Arnaud, Pierre Van Damme, Stanley A. Plotkin, et al.. (2023). Enabling the evaluation of COVID-19 vaccines with correlates of protection. Biologicals. 85. 101723–101723. 1 indexed citations
4.
Khan, Arifa S., Laurent Mallet, Johannes Blümel, et al.. (2023). Report of the third conference on next-generation sequencing for adventitious virus detection in biologics for humans and animals. Biologicals. 83. 101696–101696. 7 indexed citations
5.
Khan, Arifa S., et al.. (2022). IABS/DCVMN webinar on next generation sequencing. Biologicals. 81. 101662–101662. 2 indexed citations
6.
7.
Bekeredjian‐Ding, Isabelle, Jean‐Hugues Trouvin, Hilde Depraetere, et al.. (2021). Controlled Human Infection Studies: Proposals for guidance on how to design, develop and produce a challenge strain. Biologicals. 74. 16–23. 3 indexed citations
8.
Baay, Marc & Pieter Neels. (2021). Controlled Human Infection to Speed Up SARS-CoV-2 Vaccine Development. Frontiers in Immunology. 12. 658783–658783. 2 indexed citations
9.
Baay, Marc & Pieter Neels. (2020). SARS-CoV-2 controlled human infection models: Ethics, challenge agent production and regulatory issues. Biologicals. 67. 69–74. 12 indexed citations
10.
Khan, Arifa S., Johannes Blümel, Dieter Deforce, et al.. (2020). Report of the second international conference on next generation sequencing for adventitious virus detection in biologics for humans and animals. Biologicals. 67. 94–111. 18 indexed citations
11.
Baay, Marc, Bruno Lina, Arnaud Fontanet, et al.. (2020). SARS-CoV-2: Virology, epidemiology, immunology and vaccine development. Biologicals. 66. 35–40. 13 indexed citations
12.
Baay, Marc, Bruno Lina, Arnaud Fontanet, et al.. (2020). Virology, epidemiology, immunology and vaccine development of SARS-CoV-2, update after nine months of pandemic. Biologicals. 69. 76–82. 3 indexed citations
13.
Khan, Arifa S., Luca Benetti, Johannes Blümel, et al.. (2018). Report of the international conference on next generation sequencing for adventitious virus detection in biologicals. Biologicals. 55. 1–16. 14 indexed citations
14.
Baay, Marc, Thomas L. Richie, Pieter Neels, et al.. (2018). Human challenge trials in vaccine development, Rockville, MD, USA, September 28–30, 2017. Biologicals. 61. 85–94. 18 indexed citations
15.
Beutels, Philippe, Yannick Vandendijck, Lander Willem, et al.. (2013). Seasonal influenza vaccination: prioritizing children or other target groups?. 4 indexed citations
16.
Beutels, Philippe, Yannick Vandendijck, Lander Willem, et al.. (2013). Seasonal influenza vaccination: prioritizing children or other target groups?. 1 indexed citations
17.
Beutels, Philippe, Yannick Vandendijck, Lander Willem, et al.. (2013). Seasonal influenza vaccination: prioritizing children or other target groups?. 1 indexed citations
18.
Mastelic, Béatris, Nathalie Garçon, Giuseppe Del Giudice, et al.. (2013). Predictive markers of safety and immunogenicity of adjuvanted vaccines. Biologicals. 41(6). 458–468. 35 indexed citations
19.
Ceulemans, Berten, et al.. (2012). Successful use of fenfluramine as an add‐on treatment for Dravet syndrome. Epilepsia. 53(7). 1131–1139. 166 indexed citations
20.
Hanquet, Germaine, G Ducoffre, Anne Vergison, et al.. (2011). Impact of rotavirus vaccination on laboratory confirmed cases in Belgium. Vaccine. 29(29-30). 4698–4703. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026